SCHEMBL2819072

SCHEMBL2819072

O=C(NC1CCc2ccc(C(=O)N3CCC4(CC3)CCN(c3ccncc3)CC4)cc21)c1ccccc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 11/20 0.51
CYP2D6 P10635 9/20 0.51
TSHR P16473 8/20 0.51
CYP1A2 P05177 7/20 0.51
HIF1A Q16665 5/20 0.51
CYP2C9 P11712 11/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP2C19 P33261 7/20 0.47
USP2 O75604 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPK1 P28482 2/20 0.43
BDKRB1 P46663 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RBP4 P02753 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2821867 0.95 CYP3A4 (0.45) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484601 0.95 CYP3A4 (0.48) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484316 0.93 CYP3A4 (0.49) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL485042 0.93 CYP3A4 (0.48) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484917 0.91 CYP3A4 (0.51) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484771 0.90 CYP3A4 (0.49) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL2818085 0.90 CYP3A4 (0.53) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL485036 0.90 CYP3A4 (0.53) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484539 0.89 CYP3A4 (0.53) CYP3A4CYP2D6TSHRCYP1A2HIF1A
SCHEMBL484590 0.88 CYP3A4 (0.46) CYP3A4CYP2D6TSHRCYP1A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885TSHR 338/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885TSHR 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.